Cardlytics/$CDLX
About Cardlytics
Ticker
Sector
Industry
Employees
Cardlytics Metrics
$161M
-
-$6.04
1.54
-
Price and volume
Market cap
$161M
Beta
1.54
52-week high
$20.52
52-week low
$2.76
Average daily volume
949K
Financial strength
Current ratio
1.176
Quick ratio
1.132
Long term debt to equity
249.348
Total debt to equity
318.443
Interest coverage (TTM)
-7.65%
Management effectiveness
Return on assets (TTM)
-7.62%
Return on equity (TTM)
-186.12%
Valuation
Price to revenue (TTM)
0.49
Price to book
2.28
Price to tangible book (TTM)
-1.18
Price to free cash flow (TTM)
-5.238
Growth
Revenue change (TTM)
-3.00%
Earnings per share change (TTM)
-48.78%
3-year revenue growth (CAGR)
6.32%
3-year earnings per share growth (CAGR)
14.60%
What the Analysts think about Cardlytics
Analyst Ratings
Cardlytics Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Cardlytics Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Cardlytics News
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics, Inc. Lawsuit - CDLX
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Cardlytics, Inc.(CDLX)
Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman
What’s the current market cap for Cardlytics stock?
What is the P/E ratio for Cardlytics stock?
Does Cardlytics stock pay dividends?
No, Cardlytics (CDLX) stock does not pay dividends to its shareholders as of January 31, 2025.
When is the next Cardlytics dividend payment date?
Cardlytics (CDLX) stock does not pay dividends to its shareholders.
What is the beta indicator for Cardlytics?
Cardlytics (CDLX) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.